1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > EU5 Genetic Testing Market Outlook to 2021

EU5 Genetic Testing Market Outlook to 2021

  • October 2015
  • -
  • GlobalData
  • -
  • 147 pages

EU5 Genetic Testing Market Outlook to 2021

Summary

GlobalData’s new report, "EU5 Genetic Testing Market Outlook to 2021", provides key market data on the EU5 Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Genetic Testing market.
- Global corporate-level profiles of key companies operating within the EU5 Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

EU5 Genetic Testing Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Genetic Testing Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Genetic Testing Market, EU5 11
3.1 Genetic Testing Market, EU5, Revenue ($m), 2007-2021 11
3.2 Genetic Testing Market, EU5, Category Comparison by Revenue ($m), 2007-2021 13
3.3 Genetic Testing Market, EU5, Revenue ($m), 2007-2014 14
3.4 Genetic Testing Market, EU5, Revenue ($m), 2014-2021 16
3.5 Genetic Testing Market, EU5, Company Share by Revenue ($m), 2014 18
4 Genetic Testing Market, France 20
4.1 Genetic Testing Market, France, Revenue ($m), 2007-2014 20
4.2 Genetic Testing Market, France, Revenue ($m), 2014-2021 22
4.3 Genetic Testing Market, France, Distribution Share by Revenue ($m), 2013-2014 24
4.4 Genetic Testing Market, France, Company Share by Revenue ($m), 2014 25
5 Genetic Testing Market, Germany 27
5.1 Genetic Testing Market, Germany, Revenue ($m), 2007-2014 27
5.2 Genetic Testing Market, Germany, Revenue ($m), 2014-2021 29
5.3 Genetic Testing Market, Germany, Distribution Share by Revenue ($m), 2013-2014 31
5.4 Genetic Testing Market, Germany, Company Share by Revenue ($m), 2014 32
6 Genetic Testing Market, Italy 34
6.1 Genetic Testing Market, Italy, Revenue ($m), 2007-2014 34
6.2 Genetic Testing Market, Italy, Revenue ($m), 2014-2021 36
6.3 Genetic Testing Market, Italy, Distribution Share by Revenue ($m), 2013-2014 38
6.4 Genetic Testing Market, Italy, Company Share by Revenue ($m), 2014 39
7 Genetic Testing Market, Spain 41
7.1 Genetic Testing Market, Spain, Revenue ($m), 2007-2014 41
7.2 Genetic Testing Market, Spain, Revenue ($m), 2014-2021 43
7.3 Genetic Testing Market, Spain, Distribution Share by Revenue ($m), 2013-2014 45
7.4 Genetic Testing Market, Spain, Company Share by Revenue ($m), 2014 46
8 Genetic Testing Market, United Kingdom 48
8.1 Genetic Testing Market, United Kingdom, Revenue ($m), 2007-2014 48
8.2 Genetic Testing Market, United Kingdom, Revenue ($m), 2014-2021 50
8.3 Genetic Testing Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 52
8.4 Genetic Testing Market, United Kingdom, Company Share by Revenue ($m), 2014 53
9 Overview of Key Companies in EU5 Genetic Testing Market 55
9.1 F. Hoffmann-La Roche Ltd. 55
9.1.1 Company Overview 55
9.2 Danaher Corporation 55
9.2.1 Company Overview 55
9.3 Abbott Laboratories 55
9.3.1 Company Overview 55
9.4 Siemens Healthcare 56
9.4.1 Company Overview 56
9.5 Qiagen N.V. 56
9.5.1 Company Overview 56
9.6 Hologic, Inc. 56
9.6.1 Company Overview 56
9.7 Bio-Rad Laboratories, Inc. 57
9.7.1 Company Overview 57
9.8 PerkinElmer, Inc. 57
9.8.1 Company Overview 57
9.9 Transgenomic, Inc. 57
9.9.1 Company Overview 57
10 Genetic Testing Market Pipeline Products 58
11 Financial Deals Landscape 63
11.1 Asset Transactions 63
11.1.1 Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 63
11.2 Partnerships 65
11.2.1 KromaTiD Enters into Distribution Agreement with Tebu-bio 65
12 Recent Developments 66
12.1 Corporate Communications 66
12.1.1 Sep 21, 2015: Biotage and CEO Torben Jörgensen Have Agreed to Extend Period of Service 66
12.1.2 Jun 04, 2015: Scientific Advisory Board at Centogene 66
12.1.3 May 29, 2015: Syngene appoints talented, new International Sales Manager to provide client driven support for its high quality image analysis systems 66
12.1.4 May 19, 2015: Surgery Followed by Ipilimumab Treatment in Melanoma Patients Improves Survival, Say Moffitt Cancer Center Researchers 67
12.1.5 Jan 21, 2015: Almac Appoints VP Quality and Regulatory Affairs 68
12.1.6 Dec 01, 2014: Proteome Sciences Announces Directorate Change 68
12.1.7 Oct 16, 2014: Proteome Sciences Announces Appointment of Non-Executive Director 68
12.1.8 Sep 30, 2014: Proteome Sciences Announces Appointment Of New Finance Director 69
12.2 Financial Announcements 69
12.2.1 Sep 17, 2015: Alphatec's Arsenal Spinal Fixation System Further Expanded to Address Broader Market 69
12.2.2 Aug 25, 2015: Exiqon: Continued strong performance in the second quarter with 24% growth and profitability 70
12.2.3 Aug 13, 2015: Interim report January - June 2015 71
12.2.4 Aug 06, 2015: Epigenomics Announces Q2 2015 and 6M 2015 Financial Results and Reports on Operational Highlights 72
12.2.5 Jul 29, 2015: QIAGEN reports results for second quarter and first half of 2015 74
12.2.6 Jul 16, 2015: First made-in-singapore cancer drug enters clinical testing 79
12.2.7 Jul 13, 2015: OncoGenex Announces Custirsen Phase 3 "ENSPIRIT" Trial Continues Following Completion of Final Futility Survival Analysis 82
12.2.8 Jun 16, 2015: Alkermes to Present Data On ALKS 3831 From Late-Stage CNS Portfolio at Upcoming American Society of Clinical Psychopharmacology Annual Meeting 85
12.2.9 Jun 16, 2015: MediciNova Announces New Article Published on MN-166 in Addiction Biology 87
12.2.10 Jun 04, 2015: Momenta Pharmaceuticals Announces Oral and Poster Presentations Relating to Novel Autoimmune Programs at EULAR 2015 89
12.2.11 Jun 04, 2015: Catabasis Pharmaceuticals Announces Preliminary Phase 1 Data for Hypercholesterolemia Product Candidate CAT-2054 91
12.2.12 May 29, 2015: Proteome Sciences: Preliminary Results for Year Ended 31st December, 2014 93
12.2.13 May 12, 2015: Epigenomics Announces Q1 2015 Financial Results and Reports on Operational Highlights 96
12.2.14 May 05, 2015: QIAGEN Reports Results for First Quarter 2015 97
12.2.15 Apr 01, 2015: The Medicines Company Settles Angiomax (Bivalirudin) Patent Litigation With Sun 102
12.2.16 Mar 26, 2015: Diaxonhit Announces 2014 Annual Results 104
12.2.17 Mar 25, 2015: Epigenomics Reports Results for the Financial Year Ended December 31, 2014 and Provides Outlook for 2015 106
12.2.18 Feb 12, 2015: Biotage: Year-End Report for 2014 109
12.2.19 Jan 26, 2015: DIAXONHIT - 2014 Consolidated Income 110
12.2.20 Jan 21, 2015: Cohera Medical Enters Agreement with B. Braun Surgical for Distribution of TissuGlu Surgical Adhesive in Select European Countries 111
12.2.21 Dec 02, 2014: OGT announces operational and financial highlights for FY 2014 112
12.2.22 Nov 11, 2014: Epigenomics Announces 2014 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights 113
12.2.23 Oct 30, 2014: Biotage Interim Report For The Period January-September 2014 114
12.2.24 Sep 30, 2014: Proteome Sciences Unaudited Interim Results For The Six Months Ended 30th June 2014 116
12.3 Legal And Regulatory 119
12.3.1 Jun 16, 2015: Biotage Continued Success in Re-Examination Proceedings 119
12.3.2 Nov 11, 2014: Genovis files complaint for patent infringement by Promega 120
12.4 Other Significant Developments 120
12.4.1 Aug 19, 2015: UC Davis Scientists Spot Mutations in Circulating Tumor DNA with Ingenuity Variant Analysis 120
12.4.2 Jul 06, 2015: Microarray Instrument from Arrayjet amplifies production at Reproductive Health Science 121
12.4.3 Jun 11, 2015: SYGNIS signs second non-exclusive distribution agreement for Asia with Welgene Biotech in Taiwan 122
12.4.4 Jun 08, 2015: BHF extends funding for genetic testing of Familial Hypercholesterolaemia 123
12.4.5 Apr 27, 2015: Linkage Biosciences Partners With Italian Distributor 124
12.4.6 Mar 11, 2015: Seven Bridges Genomics UK to receive £1.95 Million to Launch Graph Genome 124
12.4.7 Mar 11, 2015: Genomics England announces successful companies in Small Business Research Initiative for a share of £8 million 125
12.4.8 Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test 125
12.4.9 Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services 126
12.4.10 Nov 27, 2014: Wieslab Laboratory Services launches new PANDAS/PANS website 126
12.5 Product News 126
12.5.1 Aug 29, 2015: Oxford starts recruiting to 100,000 Genomes Project 126
12.5.2 Jul 28, 2015: OGT expands its portfolio of Cytocell pathology FISH probes 127
12.5.3 Jun 30, 2015: Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA 127
12.5.4 Apr 23, 2015: Desktop Genetics Announces the Launch of DeskGen Gene Editing Platform 128
12.5.5 Apr 23, 2015: Merck Millipore Introduces Magna ChIRP RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs 129
12.5.6 Apr 08, 2015: Genetic screening could improve breast cancer prevention 130
12.5.7 Apr 02, 2015: Hospital trust to launch revolutionary electronic health records system 131
12.5.8 Jan 27, 2015: Scientist to develop tool to help women with breast cancer make decisions about genetic testing 132
12.5.9 Nov 25, 2014: Sophia Genetics' launches full BRCA1 and BRCA2 analysis in a single clinical grade NGS experiment 133
12.5.10 Oct 30, 2014: New Biotage SNAP ULTRA C18 Cartridges - High Performance Reversed Phase Flash Purification 134
12.5.11 Oct 20, 2014: Almac Introduce Flexible Clinical Trial Direct To Patient Solution 134
12.6 Strategy And Business Planning 135
12.6.1 Jul 10, 2015: Almac Group Expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore 135
12.6.2 Jun 06, 2015: British Healthcare Institutions Lead the Way with Cutting Edge Genetic Analysis Technology to Better Examine Cancers and Congenital Diseases 135
12.6.3 May 04, 2015: QIAGEN Partners With World's Largest Sequencing Provider 136
12.6.4 Apr 22, 2015: Transgenomic to Incorporate Horizon Discovery's Genomic Reference Standards into Multiplexed ICE COLD-PCR Kits 137
12.6.5 Mar 10, 2015: Gentronix Announces Full Membership of the UK GLP Monitoring Programme and Introduction of GLP in vitro Genotoxicity Services 138
12.6.6 Feb 05, 2015: TTP Labtech and Almac Group's Strategic Alliance Consolidates Fluorescence Lifetime Technology to Form a One-Stop Shop for Compound Screening 138
12.6.7 Jan 27, 2015: PreAnalytiX, NuGEN Technologies and RUCDR Infinite Biologics Partner to Develop Clinically Validated RNA-Seq Workflow for Whole Blood Samples 139
12.6.8 Jan 23, 2015: EKF collaborates with ANGLE to investigate the combination of Parsortix circulating tumour cell harvesting platform with PointMan DNA enrichment technology 140
12.6.9 Nov 26, 2014: ChemPartner and Active Motif form an Epigenetic Biochemical Technology Alliance 141
12.6.10 Nov 11, 2014: Horizon Discovery Group Establishes Scientific Advisory Board for Horizon Diagnostics Business Unit 141
12.6.11 Sep 30, 2014: Almac Doubles Global 2-8°C Cold Room Capacity in Response to Increasing Biologics Demand 142
13 Appendix 144
13.1 Research Methodology 145
13.1.1 Coverage 145
13.1.2 Secondary Research 145
13.1.3 Primary Research 145
13.1.4 Company Share Analysis 146
13.1.5 Distribution Share Analysis 146
13.2 GlobalData Consulting 146
13.3 Contact Us 146
13.4 Disclaimer 147

1.1 List of Tables
Table 1: Genetic Testing Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021 12
Table 2: Genetic Testing Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021 13
Table 3: Genetic Testing Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014 15
Table 4: Genetic Testing Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021 17
Table 5: Genetic Testing Market, EU5, Company Share by Revenue ($m), USD Constant, 2014 19
Table 6: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 21
Table 7: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Table 8: Genetic Testing Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 24
Table 9: Genetic Testing Market, France, Company Share by Revenue ($m), USD Constant, 2014 26
Table 10: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 28
Table 11: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Table 12: Genetic Testing Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 31
Table 13: Genetic Testing Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 33
Table 14: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 35
Table 15: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Table 16: Genetic Testing Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 38
Table 17: Genetic Testing Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 40
Table 18: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 42
Table 19: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 44
Table 20: Genetic Testing Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 45
Table 21: Genetic Testing Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 47
Table 22: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 49
Table 23: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 51
Table 24: Genetic Testing Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 52
Table 25: Genetic Testing Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 54
Table 26: Genetic Testing Market Pipeline Products 58
Table 27: Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 63
Table 28: KromaTiD Enters into Distribution Agreement with Tebu-bio 65

1.2 List of Figures
Figure 1: Genetic Testing Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021 11
Figure 2: Genetic Testing Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021 13
Figure 3: Genetic Testing Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014 14
Figure 4: Genetic Testing Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021 16
Figure 5: Genetic Testing Market, EU5, Company Share (%) 2014 18
Figure 6: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 20
Figure 7: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Figure 8: Genetic Testing Market, France, Company Share (%) 2014 25
Figure 9: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 27
Figure 10: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Figure 11: Genetic Testing Market, Germany, Company Share (%) 2014 32
Figure 12: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 34
Figure 13: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Figure 14: Genetic Testing Market, Italy, Company Share (%) 2014 39
Figure 15: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 41
Figure 16: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 43
Figure 17: Genetic Testing Market, Spain, Company Share (%) 2014 46
Figure 18: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 48
Figure 19: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 50
Figure 20: Genetic Testing Market, United Kingdom, Company Share (%) 2014 53

Companies mentioned
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Abbott Laboratories
Siemens Healthcare
Qiagen N.V.
Hologic, Inc.
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Transgenomic, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Global Genetic Testing Market By Direct to Consumer, Prenatal, Predictive and Pharmacogenomic including Test Price and Volume Forecasts with Executive and Consultant Guides 2017 to 2020

The Global Genetic Testing Market By Direct to Consumer, Prenatal, Predictive and Pharmacogenomic including Test Price and Volume Forecasts with Executive and Consultant Guides 2017 to 2020

  • $ 5495
  • Industry report
  • March 2017
  • by Howe Sound Research

“Genomic Discoveries and Direct to Consumer Drive Growth in a New Genetic Testing Industry....” Will all newborns receive Whole Genomic Sequencing at birth? How fast will Direct to Consumer Testing ...

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing ...

Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025

Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Genetic Testing Market is poised to grow at a CAGR of around 10.4% over the next decade to reach approximately $10.3 billion by 2025. Some of the prominent trends that the market is witnessing ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.